• Sundial Growers (SNDL) has announced a number of leadership changes and cost-cutting initiatives.
  • Company CEO Torsten Kuenzlen has resigned, and will be replaced by Sundial board member Zach George.
  • Other management roles have also been reappointed.
  • These events are said to be in response to “challenging industry conditions”.
  • Sundial’s share price is down 31.78 per cent, with shares trading at $1.76 apiece.

Cannabis company Sundial Growers (SNDL) has announced a number of departures and promotions in the executive team and board of directors.

Sundial has also announced company-wide cost-cutting measures, in response to “challenging industry conditions”.

Current Sundial CEO, Torsten Kuenzlen, has resigned from his position, and will also step down as a director. Zach George, a Sundial director and company board member, will replace Mr Kuenzlen as CEO.

Chairman of the Board Greg Mills spoke about the exchange of power. “We are extremely fortunate to have Mr George join us as CEO. His successful track record for effecting corporate change through increased efficiency and operational improvements, along with his capital markets experience, will help drive the next chapter for Sundial”.

Sundial’s current COO, Brian Harriman, has also left the company. His portfolio will be transferred to Andrew Stordeur, currently the President of Sundial’s Canadian operations.

In addition to taking on the role left to him by Mr Harriman, Mr Stordeur will also become company President.

Ted Hellard has stepped down from the role of Executive Chairman, but will remain a board member and Chair of the Mergers and Acquisitions Committee.

The company has also announced plans to implement several streamlining and efficiency initiatives, to ensure the company’s future. Cost-cutting measures will include facility workflow and process enhancement, workforce optimisation, and more disciplined cost management.

Sundial has admitted that this process will include reduction in staff positions at their Alberta operations.

The company has attributed these changes to “challenging industry conditions”, such as delays in regulatory approvals for new stores and cannabis 2.0 products.

In spite of industry delays adversely impacting Sundial’s operations in the short term, the company remains optimistic. Sundial hopes to see an uptick in growth, when they are finally granted regulatory approval for new products.

Sundial’s share price is down 31.78 per cent, with shares trading at $1.76 apiece.

More From The Market Online

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.

The Market Online’s Weekly Cannabis Report – April 12, 2024

Canada’s cannabis stock market fluctuated this week thanks to a combination of industry-specific developments and broader market trends

Avicanna completes topical gel study

Avicanna (TSX:AVCN) has completed its observational real-world evidence study of its RHO Phyto branded cannabigerol gel.